Neuroendocrine Tumour of the Prostate: A Rare Variant - European Medical Journal

Neuroendocrine Tumour of the Prostate: A Rare Variant

Download PDF
Ozer Ural Cakici,1 Nuran Sungu,2 Haci Ibrahim Cimen,1 Abdullah Erdem Canda,1 Ali Fuat Atmaca3

No potential conflict of interest.

EMJ - Urology. ;1:83-86. DOI/10.33590/emjurol/10313395.
Prostate, Prostate Tumour, Small-Cell Cancer

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


About 95% of prostate cancers are adenocarcinomas. Neuroendocrine differentiation (NED) is seen in virtually all cases of prostatic carcinoma, mostly in a focal pattern. Extensive NED is associated to aggressive disease with a poor prognosis and most cases are diagnosed in advanced stages.We present a 79-year- old male who was admitted to our department with severe lower urinary tract obstructive symptoms and weight loss. On digital rectal examination, the prostate was fixed to the rectum with irregular margins. Serum prostate-specific antigen (PSA) level was 1.9 ng/ml.Transrectal ultrasound-guided prostate biopsies revealed small-cell carcinoma of the prostate. Multiple metastatic lesions in vertebral bones and iliac lymph nodes were detected by nuclear bone scan and abdominal computerised tomography CT. Thereafter, the patient was treated with cisplatin-based chemotherapy and palliative radiotherapy.

Please view the full content in the pdf above.

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally